Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial

Peer Review reports

Original Submission
15 Jan 2016	Submitted	Original manuscript
6 Feb 2016	Reviewed	Reviewer Report - Mark Steben
26 Sep 2016	Reviewed	Reviewer Report - Simbarashe Takuva
8 Nov 2016	Author responded	Author comments - Sarah Nakubulwa
Resubmission - Version 2
8 Nov 2016	Submitted	Manuscript version 2
Publishing
14 Feb 2017	Editorially accepted
3 Mar 2017	Article published	10.1186/s12978-017-0292-7

Back to article page